Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource

Breast Cancer Research

Volumn 8, Issue 1, 2006, Pages

  Mann, Graham J ^a   Thorne, Heather ^b   Balleine, Rosemary L ^a   Butow, Phyllis N ^c   Clarke, Christine L ^a   Edkins, Edward ^d   Evans, Gerda M ^e   Fereday, Sián ^f   Haan, Eric ^g,h   Gattas, Michael ⁱ   Giles, Graham G ^f   Goldblatt, Jack ^j   Hopper, John L ^k   Kirk, Judy ^a   Leary, Jennifer A ^a   Lindeman, Geoffrey ^l   Niedermayr, Eveline ^b   Phillips, Kelly Anne ^b   Pickens, Sandra ^b   Pupo, Gulietta M ^a   Saunders, Christobel ^j   Scott, Clare L ^m   Spurdle, Amanda B ⁿ   Suthers, Graeme ^g,h   Tucker, Kathy ^o   Chenevix Trench, Georgia ⁿ   more..

^a WESTMEAD HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d EDITH COWAN UNIVERSITY   (Australia)

^e Breast Cancer Network Australia   (Australia)

^f CANCER EPIDEMIOLOGY CENTRE   (Australia)

^g WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^h UNIVERSITY OF ADELAIDE   (Australia)

ⁱ ROYAL CHILDREN'S HOSPITAL   (Australia)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^k UNIVERSITY OF MELBOURNE   (Australia)

^l ROYAL MELBOURNE HOSPITAL   (Australia)

^m WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

ⁿ QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^o PRINCE OF WALES HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; EPIDEMIOLOGICAL DATA; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC CODE; GENETIC DATABASE; GENETIC RISK; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MALE BREAST; MUTATIONAL ANALYSIS; NEW ZEALAND; OVARY CANCER; PREVALENCE; RISK ASSESSMENT; SITE DIRECTED MUTAGENESIS; TISSUE PRESERVATION; ALGORITHM; BREAST TUMOR; EPIDEMIOLOGY; GENETICS; GERMLINE MUTATION; HEALTH CARE FACILITY; INFORMATION PROCESSING; LABORATORY DIAGNOSIS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; ONSET AGE; ORGANIZATION AND MANAGEMENT; OVARY TUMOR; PEDIGREE; RESEARCH; RISK FACTOR; TUMOR SUPPRESSOR GENE; VERY ELDERLY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALGORITHMS; AUSTRALIA; BREAST NEOPLASMS; COHORT STUDIES; DATA COLLECTION; DNA MUTATIONAL ANALYSIS; EPIDEMIOLOGIC STUDIES; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; LIFE STYLE; MIDDLE AGED; NEW ZEALAND; OVARIAN NEOPLASMS; PEDIGREE; RESEARCH; RISK FACTORS; SPECIMEN HANDLING; TISSUE BANKS;

EID: 33644949696     PISSN: 1465542X     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1377     Document Type: Article

References (39)

1. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, et al.: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998, 62:676-689.
2. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266:66-71.
3. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G: Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378:789-792.
4. Hopper JL, Chenevix-Trench G, Jolley DJ, Dite GS, Jenkins MA, Venter DJ, McCredie MR, Giles GG: Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr 1999, 26:95-100.
5. Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjord JE: Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 1998, 352:1337-1339.
6. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, et al.: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002, 31:55-59.
7. Finkel E: Australia takes two-step approach on genetic studies. Science 1998, 280:1831-1832.
8. Osborne RH, Hopper JL, Kirk JA, Chenevix-Trench G, Thorne HJ, Sambrook JF: kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer [letter]. Med J Aust 2000, 172:463-464.
9. kConFab [http://www.kconfab.org]
10. McCredie MR, Dite GS, Giles GG, Hopper JL: Breast cancer in Australian women under the age of 40. Cancer Causes Control 1998, 9:189-198.
11. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, et al.: The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004, 6:R375-389.
12. kConFab Epidemiology Questionnaire [http://www.kconfab.org/epidemiology/ epi_questionnaire.html]
13. kConFab Dietary Questionnaire [http://www.kconfab.org/epi demiology/ diet_questionnaire.html]
14. Lum A, Le Marchand L: A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. Cancer Epidemiol Biomarkers Prev 1998, 7:719-724.
15. kConFab Biospecimen Protocol [http://www.kconfab.org/epidemiology/ biospecimen_protocol.html]
16. Xiao W, Oefner PJ: Denaturing high-performance liquid chromatography: A review. Hum Mutat 2001, 17:439-474.
17. Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, et al.: Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 2003, 63:1449-1453.
18. kConFab Classification of BRCA1 and BRCA2 Mutations [http://www.kconfab.org/progress/mutations.asp]
19. Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA, et al.: Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 2002, 94:205-215.
20. National Health and Medical Research Council Guidelines on Privacy of Genetic Information [http://www.nhmrc.gov.au/publications/pdf/e35.pdf]
21. Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, et al.: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998, 90:1138-1145.
22. kConFab Information, Policies and Procedures for Access to Biospecimens [http://www.kconfab.org/access/policy.html]
23. Tyrer J, Duffy SW, Cuzick J: A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004, 23:1111-1130.
24. kConFab Projects [http://www.kconfab.org/research/index.html]
25. Publications [http://www.kconfab.org/progress/publications.html]
26. Marsh A, Spurdle AB, Turner BC, Fereday S, Thorne H, Pupo GM, Mann GJ, Hopper JL, Sambrook JF, Chenevix-Trench G: The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia. Breast Cancer Res 2001, 3:346-349.
27. Wang WW, Spurdle AB, Kolachana P, Bove B, Modan B, Ebbers SM, Suthers G, Tucker MA, Kaufman DJ, Doody MM, et al.: A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2001, 10:955-960.
28. Butow PN, Hiller J, Price M, Thackaway S, Kricker A, Tennant C: Empirical evidence for a relationship between life events, coping style and personality factors in the development of breast cancer. J Psychosom Res 2000, 49:169-181.
29. Butow P, Davenport T, Bennett B, Meiser B, Hickie I, Tucker K, Price M, kCoNFab: Psychological morbidity in women at increased risk of developing breast cancer: a controlled study. Psychooncology 2005, 14:196-203.
30. Thompson D, Szabo CI, Mangion J, Oldenburg RA, Odefrey F, Seal S, Barfoot R, Kroeze-Jansema K, Teare D, Rahman N, et al.: Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci USA 2002, 99:827-831.
31. Scott CL, Jenkins MA, Southey MC, Davis TA, Leary JA, Easton DF, Phillips KA, Hopper JL: Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics. Hum Genet 2003, 112:542-551.
32. Scott CI, Iorgulescu DG, Thorne HJ, Henderson MA, Phillips KA: Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy. Clin Genet 2003, 64:111-121.
33. Southey MC, Tesoriero A, Young MA, Holloway AJ, Jenkins MA, Whitty J, Misfud S, kConFab, McLachlan SA, Venter DJ, et al.: A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1. Hum Mutat 2003, 22:86-91.
34. Meiser B, Butow P, Price M, Bennett B, Berry G, Tucker K: Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer. J Womens Health (Larchmt) 2003, 12:769-778.
35. Lim J, Macluran M, Price M, Bennett B, Butow P, kCoNFab: Short and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer. J Genet Couns 2004, 13:115-133.
36. Mote PA, Leary JA, Avery KA, Sandelin K, Chenevix-Trench G, Kirk JA, Clarke CL: Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A. Genes Chromosomes Cancer 2004, 39:236-248.
37. Campbell IG, Choong D, Chenevix-Trench G: No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer. Breast Cancer Res 2004, 6:R366-371.
38. kConFab Members [http://www.kConFab.org/organisation/members.html]
39. Australian National Breast Cancer Centre Guidelines for High Risk of Breast Cancer [http://www.nbcc.com.au]